“Two-phase”的搜索结果，显示 221-230 项，共有 4314 项

1. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Rochester, Minn. This is a randomized Phase 2 study of novel SEQUEnced immunotherapy (pembrolizumab) with anti-angiogenesis and chemotherapy in advanced gastric ...

2. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... phase. Defining the Immunologic Profile of Sentinel Lymph Nodes and ... two prior lines of therapies. The study has 2 Modules: Module 1 for FL and Module 2 for ...

3. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The purpose of this study is to determine the maximum tolerated dose (MTD) and schedule and/or a recommended Phase 2 ... phase II dose (RP2D of APG2575 in ...

4. 听觉科- 临床试验- 妙佑医疗国际

   ... two future steps: Hearing Genomics. Rochester, Minn. Aims, purpose, or objectives: 1) Develop hypotheses related to how the human genome and genetic variants ...

5. 神经科- 临床试验- 妙佑医疗国际

   The purpose of phase 2 of this trial is to evaluate the effectiveness of sequentially administering temozolomide and selinexor in recurrent glioblastoma as ...

6. 泌尿科- 临床试验- 妙佑医疗国际

   Rochester, Minn. This is an international phase III trial, with a Bayesian design, incorporating two sequential randomisations. It efficiently examines a ...

7. 血液科- 临床试验- 妙佑医疗国际

   Study B9991011 is a multi-center, international, randomized, open label, 2 component (Phase ... Most newly-diagnosed CLL patients have early-stage disease at the ...

8. 妇产科- 临床试验- 妙佑医疗国际

   ... phase 2 dose (RP2D) 1.1.2 To evaluate the safety and tolerability of this combination in a dose expansion cohort in patients with uterine serous carcinoma.

9. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   This is a randomized Phase 2 study of novel SEQUEnced immunotherapy (pembrolizumab) with anti-angiogenesis and chemotherapy in advanced gastric and ...

10. 脂肪肝病（MASLD） - 症状与病因- 妙佑医疗国际

    代谢功能障碍相关脂肪变性肝病（MASLD）是一种肝脏状况，以前被称为非酒精性脂肪性肝病（NAFLD），会影响超重、肥胖症或患有其他代谢状况（例如2 型糖尿病、高血压或高 ...